Jan Beyer‐Westendorf
About
Jan Beyer‐Westendorf is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery.
According to data from OpenAlex, Jan Beyer‐Westendorf has authored 190 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 149 papers in Cardiology and Cardiovascular Medicine, 142 papers in Internal Medicine and 31 papers in Surgery. Recurrent topics in Jan Beyer‐Westendorf's work include Venous Thromboembolism Diagnosis and Management (142 papers), Atrial Fibrillation Management and Outcomes (135 papers) and Cardiac Arrhythmias and Treatments (23 papers). Jan Beyer‐Westendorf is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (142 papers), Atrial Fibrillation Management and Outcomes (135 papers) and Cardiac Arrhythmias and Treatments (23 papers). Jan Beyer‐Westendorf collaborates with scholars based in Germany, United Kingdom and United States. Jan Beyer‐Westendorf's co-authors include Sebastian Werth, Luise Tittl, Walter Ageno, Bruce L. Davidson, Franziska Michalski, Sandra Marten, Per Morten Sandset, Saskia Middeldorp, Karlyn A. Martin and Stephan Moll and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.
In The Last Decade
Jan Beyer‐Westendorf
175 papers receiving 5.1k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jan Beyer‐Westendorf Germany | 35 | 3.8k | 3.4k | 1.0k | 745 | 690 | 190 | 5.2k | ||
| Philip Wells Canada | 22 | 4.6k 1.2× | 3.1k 0.9× | 1.5k 1.4× | 623 0.8× | 982 1.4× | 34 | 5.8k | ||
| Janine Vintch United States | 10 | 3.7k 1.0× | 2.4k 0.7× | 1.2k 1.1× | 552 0.7× | 511 0.7× | 29 | 4.2k | ||
| Geno J. Merli United States | 37 | 4.8k 1.2× | 3.8k 1.1× | 1.7k 1.6× | 521 0.7× | 723 1.0× | 155 | 6.3k | ||
| Namita Sood United States | 13 | 3.0k 0.8× | 2.3k 0.7× | 989 0.9× | 451 0.6× | 669 1.0× | 42 | 4.2k | ||
| Alexander T. Cohen United Kingdom | 19 | 4.8k 1.3× | 3.7k 1.1× | 1.2k 1.1× | 459 0.6× | 788 1.1× | 44 | 5.3k | ||
| Juan I. Arcelus Spain | 15 | 4.9k 1.3× | 3.2k 1.0× | 1.6k 1.6× | 463 0.6× | 749 1.1× | 20 | 5.8k | ||
| Joseph Ornelas United States | 8 | 3.0k 0.8× | 2.0k 0.6× | 1.0k 1.0× | 400 0.5× | 421 0.6× | 9 | 3.7k | ||
| Gregory Piazza United States | 33 | 2.5k 0.6× | 1.6k 0.5× | 1.1k 1.1× | 899 1.2× | 365 0.5× | 160 | 4.0k | ||
| Christopher S. King United States | 24 | 3.8k 1.0× | 2.6k 0.8× | 1.4k 1.3× | 719 1.0× | 532 0.8× | 128 | 5.7k | ||
| Robert D. McBane United States | 44 | 3.5k 0.9× | 3.4k 1.0× | 2.0k 1.9× | 751 1.0× | 988 1.4× | 262 | 6.7k |
Countries citing papers authored by Jan Beyer‐Westendorf
Since
Specialization
Citations
This map shows the geographic impact of Jan Beyer‐Westendorf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Beyer‐Westendorf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Beyer‐Westendorf more than expected).
Fields of papers citing papers by Jan Beyer‐Westendorf
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jan Beyer‐Westendorf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Beyer‐Westendorf. The network helps show where Jan Beyer‐Westendorf may publish in the future.
Co-authorship network of co-authors of Jan Beyer‐Westendorf
This figure shows the co-authorship network connecting the top 25 collaborators of Jan Beyer‐Westendorf. A scholar is included among the top collaborators of Jan Beyer‐Westendorf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Beyer‐Westendorf. Jan Beyer‐Westendorf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Birschmann, Ingvild, Simone Lindau, Stavros Konstantinides, et al.. (2025). Anticoagulant Management After Emergency Surgery or Major Bleeding in Anticoagulated Patients—Results of the Prospective RADOA Registry. Pharmaceuticals. 18(2). 170–170.
2.
Kreutz, Reinhold, Gilbert Deray, Jürgen Floege, et al.. (2024). Risk Profiles and Treatment Patterns in Atrial Fibrillation Patients with Chronic Kidney Disease Receiving or not Receiving Anticoagulation Therapy. SHILAP Revista de lepidopterología. 8(1). e106–e113.
3.
Horn, MacKenzie, Ondřej Volný, Hyun Seok Choi, et al.. (2024). Total intracranial hemorrhage volume measurement summating all compartments best in traumatic and nontraumatic intracranial bleeding. Brain and Behavior. 14(5). e3481–e3481.
4.
Herrmann, Eva, Ingvild Birschmann, Simone Lindau, et al.. (2024). Clinical Course and Management of Patients with Emergency Surgery Treated with Direct Oral Anticoagulants or Vitamin K Antagonists—Results of the German Prospective RADOA-Registry. Journal of Clinical Medicine. 13(1). 272–272.
5.
Kraaijpoel, Noémie, Frits I. Mulder, Marc Carrier, et al.. (2023). OC 46.1 Absolute Quantitative Proteomics for Occult Cancer Screening in Patient with Unprovoked Venous Thromboembolism: Results from the Prospective PLATO-VTE Study. Research and Practice in Thrombosis and Haemostasis. 7. 100597–100597.
6.
Jong, Cindy M.M. de, Marc Blondon, Cihan Ay, et al.. (2022). Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism. Blood. 140(16). 1764–1773.
7.
Vicent, O., Andreas Güldner, Jürgen Schmidt, et al.. (2022). Enhancing Anticoagulation Monitoring and Therapy in Patients Undergoing Microvascular Reconstruction in Maxillofacial Surgery: A Prospective Observational Trial. Journal of Personalized Medicine. 12(8). 1229–1229.
8.
Sedghi, Annahita, Anna Klimová, Oliver Tiebel, et al.. (2022). Point-of-Care Assessment of Direct Oral Anticoagulation in Acute Ischemic Stroke: Protocol for a Prospective Observational Diagnostic Accuracy Study. Thrombosis and Haemostasis. 122(11). 1954–1962.
9.
Maraveyas, Anthony, Noémie Kraaijpoel, George Bozas, et al.. (2021). The prognostic value of respiratory symptoms and performance status in ambulatory cancer patients and unsuspected pulmonary embolism; analysis of an international, prospective, observational cohort study. Journal of Thrombosis and Haemostasis. 19(11). 2791–2800.
10.
Beyer‐Westendorf, Jan, Veronica Ashton, Dejan Milentijevic, et al.. (2020). Effectiveness and safety of rivaroxaban versus warfarin in obese nonvalvular atrial fibrillation patients: analysis of electronic health record data. Current Medical Research and Opinion. 36(7). 1081–1088.
11.
Valeriani, Emanuele, Marcello Di Nisio, Nicoletta Riva, et al.. (2020). Clinical history of cancer‐associated splanchnic vein thrombosis. Journal of Thrombosis and Haemostasis. 19(4). 983–991.
12.
Barco, Stefano, Serena Granziera, Michiel Coppens, et al.. (2019). Determinants of the Quality of Warfarin Control after Venous Thromboembolism and Validation of the SAMe-TT2-R2 Score: An Analysis of Hokusai-VTE. Thrombosis and Haemostasis. 119(4). 675–684.
13.
Schünemann, Holger J., Mary Cushman, Allison Burnett, et al.. (2018). American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Advances. 2(22). 3198–3225.
14.
Tittl, Luise, et al.. (2018). Impact of BMI on clinical outcomes of NOAC therapy in daily care - Results of the prospective Dresden NOAC Registry (NCT01588119). International Journal of Cardiology. 262. 85–91.
15.
Cohen, Alexander T., et al.. (2018). COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study. Thrombosis Journal. 16(1).
16.
Kohn, Christine G., Gary H. Lyman, Jan Beyer‐Westendorf, et al.. (2017). Effectiveness and Safety of Rivaroxaban in Patients with Cancer-Associated Venous Thromboembolism. Blood. 130. 3717–3717.
17.
Martin, Karlyn A., Jan Beyer‐Westendorf, Bruce L. Davidson, et al.. (2016). Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 14(6). 1308–1313.
18.
Riva, Nicoletta, Walter Ageno, Sam Schulman, et al.. (2013). Antithrombotic treatment of splanchnic vein thrombosis in the ISTH international registry: results of 6-month follow-up. Journal of Thrombosis and Haemostasis. 11. 87–88.
19.
Donath, Lars, Jörg Lützner, Sebastian Werth, et al.. (2012). Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery – findings from the ORTHO‐TEP registry. British Journal of Clinical Pharmacology. 74(6). 947–958.
20.
Beyer‐Westendorf, Jan, et al.. (2012). Efficacy and safety of venous thromboembolism prophylaxis with apixaban in major orthopedic surgery. Therapeutics and Clinical Risk Management. 8. 139–139.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Philip Wells Breakdown of academic impact, for papers by Janine Vintch Breakdown of academic impact, for papers by Geno J. Merli Breakdown of academic impact, for papers by Namita Sood Breakdown of academic impact, for papers by Alexander T. Cohen Breakdown of academic impact, for papers by Juan I. Arcelus Breakdown of academic impact, for papers by Joseph Ornelas Breakdown of academic impact, for papers by Gregory Piazza Breakdown of academic impact, for papers by Christopher S. King Breakdown of academic impact, for papers by Robert D. McBane